Butorphanol Tartrate
NDC Package 55154-0366-5

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Butorphanol Tartrate is a medication used to treat moderate to severe pain, including pain from surgery, muscle pain, and migraine headaches. Marketed by Cardinal Health, this product is identified by NDC 55154-0366 and is authorized under FDA application ANDA075045.

Identification & Billing

NDC Package Code
55154-0366-5
Package Description
5 VIAL in 1 BAG / 1 mL in 1 VIAL
Product Code
55154-0366
11-Digit Billing Format
55154036605

Clinical Specifications

Proprietary Name
Butorphanol Tartrate
Dosage Form
-
Usage Information
This medication is used to treat moderate to severe pain, including pain from surgery, muscle pain, and migraine headaches. Butorphanol is an opioid pain reliever similar to morphine. It acts on certain centers in the brain to give you pain relief. Butorphanol can also block the effects of opioids and can cause withdrawal symptoms in people dependent on opioids. If possible, people who have recently used opioids in high doses or for a long time should not use butorphanol. (See also Side Effects section.)

Regulatory & Marketing

Labeler Name
Cardinal Health
FDA Application #
ANDA075045
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
10-15-1998
End Marketing Date
01-31-2012
Listing Expiration
01-31-2012
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55154-0366-5 identifies a specific commercial package of 5 vial in 1 bag / 1 ml in 1 vial of Butorphanol Tartrate, labeled by Cardinal Health. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Cardinal Health on October 15, 1998. The current certification is valid through January 31, 2012.

What are the primary indications for this medication?

This medication is used to treat moderate to severe pain, including pain from surgery, muscle pain, and migraine headaches. Butorphanol is an opioid pain reliever similar to morphine. It acts on certain centers in the brain to give you pain relief. Butorphanol can also block the effects of opioids and can cause withdrawal symptoms in people dependent on opioids. If possible, people who have recently used opioids in high doses or for a long time should not use butorphanol. (See also Side Effects section.)

How is this Cardinal Health product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55154036605. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
55154-0366-5
11-Digit CMS (5-4-2)
55154-0366-05

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.